150mg Neuzumab Trastuzumab Injection

Name: 150mg Neuzumab Trastuzumab Injection
Brand: Amari Trade Alliance LLP
Price: 6850 INR
Availability: InStock

Price 6850 INR/ Vial

Get a Price/Quote

MOQ : 2 Vials

150mg Neuzumab Trastuzumab Injection Specification

Origin of Medicine
India

Indication
Breast cancer, gastric cancer

Pacakaging (Quantity Per Box)
1 vial

Dosage Form
Injection

Life Span
24 months

Brand Name
Neuzumab

Salt Composition
Trastuzumab

Packaging Type
Vial

Drug Type
Biological

Ingredients
Trastuzumab

Physical Form
Injection

Function
Anticancer

Recommended For
HER2-positive breast cancer

Dosage
150mg vial

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
150mg

Storage Instructions
Store at 2C-8C

Route of Administration
Intravenous use

HER2-Targeting
Yes

Prescription Status
Prescription only

Usage Type
B2B Resale

Monoclonal Antibody
Yes

Preservative-Free
Yes

Sterility
Sterile powder

Strength
150mg

Reconstitution Solvent
Not included

Dilution Required
Yes

150mg Neuzumab Trastuzumab Injection Trade Information

Minimum Order Quantity
2 Vials

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

About 150mg Neuzumab Trastuzumab Injection

Introducing the new release of Neuzumab Trastuzumab Injection, a triumphant advancement in HER2-positive cancer therapy. This featured 150mg vial-crafted as a sterile, preservative-free, and immaculate monoclonal antibody-offers robust efficacy for adult patients battling HER2-positive breast and gastric cancers. Reserved exclusively for prescription use, Neuzumab's lofty safety standards and potent mechanism make it an ideal choice for medical exporters, suppliers, and traders. Supplied as a lyophilized powder requiring dilution, it embodies precision and reliability for B2B resale. Manufactured in India, this life-saving innovation ensures consistent, targeted therapeutic results.

Versatile Applications and Prime Features

Neuzumab Trastuzumab Injection (150mg) is recommended for adults requiring HER2-positive breast or gastric cancer treatment. The application area focuses on intravenous administration by healthcare professionals, with reconstitution required before use. Its immaculate formulation is preservative-free, sterile, and designed for maximum efficacy. Suitable for clinical settings, this monoclonal antibody targets the HER2 receptor, providing precision in oncological therapy. Packaged in a single vial, Neuzumab sets a new benchmark in cancer care solutions.

Reliable Supply, Secure Packaging, Rapid Delivery

Our Neuzumab Trastuzumab Injection offers steady supply ability for global buyers, whether exporter, supplier, or trader. Each 150mg vial is packaged securely to maintain sterility and integrity throughout transit, kept at 2C-8C for optimal preservation. Rate options available ensure competitive pricing for bulk B2B orders. With express shipping and robust logistics, delivery time is minimized, ensuring your consignment arrives promptly and safely, ready for immediate use in clinical environments.

FAQ's of 150mg Neuzumab Trastuzumab Injection:

Q: How should the Neuzumab Trastuzumab Injection be prepared before administration?

A: Neuzumab Trastuzumab Injection requires dilution and reconstitution with a solvent (not included). Preparation must be done by qualified healthcare professionals as per physician's guidelines.

Q: What cancers is Neuzumab Trastuzumab Injection indicated for?

A: Neuzumab is indicated for the treatment of HER2-positive breast cancer and gastric cancer in adult patients, providing a targeted therapeutic benefit.

Q: When is the best time to administer Neuzumab Trastuzumab Injection?

A: Neuzumab should be administered according to the treatment schedule prescribed by a physician, typically during chemotherapy cycles in a clinical setting.

Q: Where should the Neuzumab Injection be stored before use?

A: Store the Neuzumab vials at a temperature between 2C-8C in a refrigerator, and ensure they remain protected from light and freezing conditions.

Q: What are the main benefits of using Neuzumab for HER2-positive cancers?

A: Neuzumab offers a targeted monoclonal antibody approach, increasing treatment efficacy while minimizing off-target effects, resulting in improved outcomes for HER2-positive cancer patients.